Are you Dr. Bilenker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Landmark Sq
1122
Stamford, CT 06901Phone+1 203-653-3881
Summary
- Dr. Joshua Bilenker, MD is an oncologist in Stamford, Connecticut. He is currently licensed to practice medicine in Connecticut.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2001 - 2005- University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2001
Johns Hopkins University School of MedicineClass of 1999
Certifications & Licensure
CT State Medical License 2007 - 2024
Publications & Presentations
PubMed
- 79 citationsPhase I trial of combretastatin a-4 phosphate with carboplatin.Joshua H. Bilenker, Keith T. Flaherty, Mark A. Rosen, Lisa E. Davis, Maryann Gallagher
Clinical Cancer Research. 2005-02-15 - 6 citationsPhase I trial of the novel taxane BMS-184476 administered in combination with carboplatin every 21 days.Joshua H. Bilenker, James P. Stevenson, Maryann Gallagher, David J. Vaughn, Marvin B. Cohen
British Journal of Cancer. 2004-07-13 - 3 citationsFuture Directions with Angiogenesis Inhibitors in Colorectal CancerJoshua H. Bilenker, Daniel G. Haller
Clinical Colorectal Cancer. 2004-10-01
Press Mentions
- Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business UpdatesMarch 24th, 2021
Eli Lilly to Buy Loxo Oncology for $8 Billion in Huge Bet on Cancer GeneticsJanuary 7th, 2019
Gossamer Bio Announces Appointment of New Independent DirectorsDecember 19th, 2018
